Global Sitagliptin Metformin Extended Release Tablets Supply, Demand and Key Producers, 2024-2030

Page: 108

Published Date: 09 Sep 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Sitagliptin Metformin Extended Release Tablets is a combination drug used to treat type 2 diabetes. Through the synergistic effect of sitagliptin and metformin, it helps patients better control blood sugar levels. This drug is suitable for patients who have poor blood sugar control through diet and exercise. It can lower blood sugar and improve insulin resistance through different mechanisms.

The global Sitagliptin Metformin Extended Release Tablets market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Sitagliptin Metformin Extended Release Tablets production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Sitagliptin Metformin Extended Release Tablets and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Sitagliptin Metformin Extended Release Tablets that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Sitagliptin Metformin Extended Release Tablets total production and demand, 2019-2030, (K Units)
Global Sitagliptin Metformin Extended Release Tablets total production value, 2019-2030, (USD Million)
Global Sitagliptin Metformin Extended Release Tablets production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Sitagliptin Metformin Extended Release Tablets consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Sitagliptin Metformin Extended Release Tablets domestic production, consumption, key domestic manufacturers and share
Global Sitagliptin Metformin Extended Release Tablets production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Sitagliptin Metformin Extended Release Tablets production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Sitagliptin Metformin Extended Release Tablets production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Sitagliptin Metformin Extended Release Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Anbisheng Pharmaceutical Co., Ltd., Jiangsu Xuantai Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group, Merck & Co., Inc., Abbott, Sandoz Pty Ltd, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Sitagliptin Metformin Extended Release Tablets market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Sitagliptin Metformin Extended Release Tablets Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Sitagliptin Metformin Extended Release Tablets Market, Segmentation by Type:
    Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
    Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg

Global Sitagliptin Metformin Extended Release Tablets Market, Segmentation by Application:
    Hospital
    Clinic
    Other

Companies Profiled:
    Jiangsu Anbisheng Pharmaceutical Co., Ltd.
    Jiangsu Xuantai Pharmaceutical Co., Ltd.
    Chia Tai Tianqing Pharmaceutical Group
    Merck & Co., Inc.
    Abbott
    Sandoz Pty Ltd

Key Questions Answered:
1. How big is the global Sitagliptin Metformin Extended Release Tablets market?
2. What is the demand of the global Sitagliptin Metformin Extended Release Tablets market?
3. What is the year over year growth of the global Sitagliptin Metformin Extended Release Tablets market?
4. What is the production and production value of the global Sitagliptin Metformin Extended Release Tablets market?
5. Who are the key producers in the global Sitagliptin Metformin Extended Release Tablets market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Sitagliptin Metformin Extended Release Tablets Introduction
    1.2 World Sitagliptin Metformin Extended Release Tablets Supply & Forecast
        1.2.1 World Sitagliptin Metformin Extended Release Tablets Production Value (2019 & 2023 & 2030)
        1.2.2 World Sitagliptin Metformin Extended Release Tablets Production (2019-2030)
        1.2.3 World Sitagliptin Metformin Extended Release Tablets Pricing Trends (2019-2030)
    1.3 World Sitagliptin Metformin Extended Release Tablets Production by Region (Based on Production Site)
        1.3.1 World Sitagliptin Metformin Extended Release Tablets Production Value by Region (2019-2030)
        1.3.2 World Sitagliptin Metformin Extended Release Tablets Production by Region (2019-2030)
        1.3.3 World Sitagliptin Metformin Extended Release Tablets Average Price by Region (2019-2030)
        1.3.4 North America Sitagliptin Metformin Extended Release Tablets Production (2019-2030)
        1.3.5 Europe Sitagliptin Metformin Extended Release Tablets Production (2019-2030)
        1.3.6 China Sitagliptin Metformin Extended Release Tablets Production (2019-2030)
        1.3.7 Japan Sitagliptin Metformin Extended Release Tablets Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Sitagliptin Metformin Extended Release Tablets Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Sitagliptin Metformin Extended Release Tablets Major Market Trends

2 Demand Summary
    2.1 World Sitagliptin Metformin Extended Release Tablets Demand (2019-2030)
    2.2 World Sitagliptin Metformin Extended Release Tablets Consumption by Region
        2.2.1 World Sitagliptin Metformin Extended Release Tablets Consumption by Region (2019-2024)
        2.2.2 World Sitagliptin Metformin Extended Release Tablets Consumption Forecast by Region (2025-2030)
    2.3 United States Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030)
    2.4 China Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030)
    2.5 Europe Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030)
    2.6 Japan Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030)
    2.7 South Korea Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030)
    2.8 ASEAN Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030)
    2.9 India Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Sitagliptin Metformin Extended Release Tablets Production Value by Manufacturer (2019-2024)
    3.2 World Sitagliptin Metformin Extended Release Tablets Production by Manufacturer (2019-2024)
    3.3 World Sitagliptin Metformin Extended Release Tablets Average Price by Manufacturer (2019-2024)
    3.4 Sitagliptin Metformin Extended Release Tablets Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Sitagliptin Metformin Extended Release Tablets Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Sitagliptin Metformin Extended Release Tablets in 2023
        3.5.3 Global Concentration Ratios (CR8) for Sitagliptin Metformin Extended Release Tablets in 2023
    3.6 Sitagliptin Metformin Extended Release Tablets Market: Overall Company Footprint Analysis
        3.6.1 Sitagliptin Metformin Extended Release Tablets Market: Region Footprint
        3.6.2 Sitagliptin Metformin Extended Release Tablets Market: Company Product Type Footprint
        3.6.3 Sitagliptin Metformin Extended Release Tablets Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Sitagliptin Metformin Extended Release Tablets Production Value Comparison
        4.1.1 United States VS China: Sitagliptin Metformin Extended Release Tablets Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Sitagliptin Metformin Extended Release Tablets Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Sitagliptin Metformin Extended Release Tablets Production Comparison
        4.2.1 United States VS China: Sitagliptin Metformin Extended Release Tablets Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Sitagliptin Metformin Extended Release Tablets Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Sitagliptin Metformin Extended Release Tablets Consumption Comparison
        4.3.1 United States VS China: Sitagliptin Metformin Extended Release Tablets Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Sitagliptin Metformin Extended Release Tablets Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Sitagliptin Metformin Extended Release Tablets Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Sitagliptin Metformin Extended Release Tablets Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production (2019-2024)
    4.5 China Based Sitagliptin Metformin Extended Release Tablets Manufacturers and Market Share
        4.5.1 China Based Sitagliptin Metformin Extended Release Tablets Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Value (2019-2024)
        4.5.3 China Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production (2019-2024)
    4.6 Rest of World Based Sitagliptin Metformin Extended Release Tablets Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Sitagliptin Metformin Extended Release Tablets Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production (2019-2024)

5 Market Analysis by Type
    5.1 World Sitagliptin Metformin Extended Release Tablets Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
        5.2.2 Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
    5.3 Market Segment by Type
        5.3.1 World Sitagliptin Metformin Extended Release Tablets Production by Type (2019-2030)
        5.3.2 World Sitagliptin Metformin Extended Release Tablets Production Value by Type (2019-2030)
        5.3.3 World Sitagliptin Metformin Extended Release Tablets Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Sitagliptin Metformin Extended Release Tablets Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Sitagliptin Metformin Extended Release Tablets Production by Application (2019-2030)
        6.3.2 World Sitagliptin Metformin Extended Release Tablets Production Value by Application (2019-2030)
        6.3.3 World Sitagliptin Metformin Extended Release Tablets Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Jiangsu Anbisheng Pharmaceutical Co., Ltd.
        7.1.1 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Details
        7.1.2 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Major Business
        7.1.3 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product and Services
        7.1.4 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
        7.1.6 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
    7.2 Jiangsu Xuantai Pharmaceutical Co., Ltd.
        7.2.1 Jiangsu Xuantai Pharmaceutical Co., Ltd. Details
        7.2.2 Jiangsu Xuantai Pharmaceutical Co., Ltd. Major Business
        7.2.3 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product and Services
        7.2.4 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments/Updates
        7.2.6 Jiangsu Xuantai Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
    7.3 Chia Tai Tianqing Pharmaceutical Group
        7.3.1 Chia Tai Tianqing Pharmaceutical Group Details
        7.3.2 Chia Tai Tianqing Pharmaceutical Group Major Business
        7.3.3 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product and Services
        7.3.4 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
        7.3.6 Chia Tai Tianqing Pharmaceutical Group Competitive Strengths & Weaknesses
    7.4 Merck & Co., Inc.
        7.4.1 Merck & Co., Inc. Details
        7.4.2 Merck & Co., Inc. Major Business
        7.4.3 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product and Services
        7.4.4 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Merck & Co., Inc. Recent Developments/Updates
        7.4.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
    7.5 Abbott
        7.5.1 Abbott Details
        7.5.2 Abbott Major Business
        7.5.3 Abbott Sitagliptin Metformin Extended Release Tablets Product and Services
        7.5.4 Abbott Sitagliptin Metformin Extended Release Tablets Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Abbott Recent Developments/Updates
        7.5.6 Abbott Competitive Strengths & Weaknesses
    7.6 Sandoz Pty Ltd
        7.6.1 Sandoz Pty Ltd Details
        7.6.2 Sandoz Pty Ltd Major Business
        7.6.3 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product and Services
        7.6.4 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Sandoz Pty Ltd Recent Developments/Updates
        7.6.6 Sandoz Pty Ltd Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Sitagliptin Metformin Extended Release Tablets Industry Chain
    8.2 Sitagliptin Metformin Extended Release Tablets Upstream Analysis
        8.2.1 Sitagliptin Metformin Extended Release Tablets Core Raw Materials
        8.2.2 Main Manufacturers of Sitagliptin Metformin Extended Release Tablets Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Sitagliptin Metformin Extended Release Tablets Production Mode
    8.6 Sitagliptin Metformin Extended Release Tablets Procurement Model
    8.7 Sitagliptin Metformin Extended Release Tablets Industry Sales Model and Sales Channels
        8.7.1 Sitagliptin Metformin Extended Release Tablets Sales Model
        8.7.2 Sitagliptin Metformin Extended Release Tablets Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Sitagliptin Metformin Extended Release Tablets Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Sitagliptin Metformin Extended Release Tablets Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Sitagliptin Metformin Extended Release Tablets Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Sitagliptin Metformin Extended Release Tablets Production Value Market Share by Region (2019-2024)
 Table 5. World Sitagliptin Metformin Extended Release Tablets Production Value Market Share by Region (2025-2030)
 Table 6. World Sitagliptin Metformin Extended Release Tablets Production by Region (2019-2024) & (K Units)
 Table 7. World Sitagliptin Metformin Extended Release Tablets Production by Region (2025-2030) & (K Units)
 Table 8. World Sitagliptin Metformin Extended Release Tablets Production Market Share by Region (2019-2024)
 Table 9. World Sitagliptin Metformin Extended Release Tablets Production Market Share by Region (2025-2030)
 Table 10. World Sitagliptin Metformin Extended Release Tablets Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Sitagliptin Metformin Extended Release Tablets Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Sitagliptin Metformin Extended Release Tablets Major Market Trends
 Table 13. World Sitagliptin Metformin Extended Release Tablets Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Sitagliptin Metformin Extended Release Tablets Consumption by Region (2019-2024) & (K Units)
 Table 15. World Sitagliptin Metformin Extended Release Tablets Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Sitagliptin Metformin Extended Release Tablets Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Sitagliptin Metformin Extended Release Tablets Producers in 2023
 Table 18. World Sitagliptin Metformin Extended Release Tablets Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Sitagliptin Metformin Extended Release Tablets Producers in 2023
 Table 20. World Sitagliptin Metformin Extended Release Tablets Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Sitagliptin Metformin Extended Release Tablets Company Evaluation Quadrant
 Table 22. World Sitagliptin Metformin Extended Release Tablets Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Sitagliptin Metformin Extended Release Tablets Production Site of Key Manufacturer
 Table 24. Sitagliptin Metformin Extended Release Tablets Market: Company Product Type Footprint
 Table 25. Sitagliptin Metformin Extended Release Tablets Market: Company Product Application Footprint
 Table 26. Sitagliptin Metformin Extended Release Tablets Competitive Factors
 Table 27. Sitagliptin Metformin Extended Release Tablets New Entrant and Capacity Expansion Plans
 Table 28. Sitagliptin Metformin Extended Release Tablets Mergers & Acquisitions Activity
 Table 29. United States VS China Sitagliptin Metformin Extended Release Tablets Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Sitagliptin Metformin Extended Release Tablets Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Sitagliptin Metformin Extended Release Tablets Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Sitagliptin Metformin Extended Release Tablets Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Market Share (2019-2024)
 Table 37. China Based Sitagliptin Metformin Extended Release Tablets Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Market Share (2019-2024)
 Table 42. Rest of World Based Sitagliptin Metformin Extended Release Tablets Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Market Share (2019-2024)
 Table 47. World Sitagliptin Metformin Extended Release Tablets Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Sitagliptin Metformin Extended Release Tablets Production by Type (2019-2024) & (K Units)
 Table 49. World Sitagliptin Metformin Extended Release Tablets Production by Type (2025-2030) & (K Units)
 Table 50. World Sitagliptin Metformin Extended Release Tablets Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Sitagliptin Metformin Extended Release Tablets Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Sitagliptin Metformin Extended Release Tablets Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Sitagliptin Metformin Extended Release Tablets Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Sitagliptin Metformin Extended Release Tablets Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Sitagliptin Metformin Extended Release Tablets Production by Application (2019-2024) & (K Units)
 Table 56. World Sitagliptin Metformin Extended Release Tablets Production by Application (2025-2030) & (K Units)
 Table 57. World Sitagliptin Metformin Extended Release Tablets Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Sitagliptin Metformin Extended Release Tablets Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Sitagliptin Metformin Extended Release Tablets Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Sitagliptin Metformin Extended Release Tablets Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 62. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Major Business
 Table 63. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product and Services
 Table 64. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 66. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
 Table 67. Jiangsu Xuantai Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 68. Jiangsu Xuantai Pharmaceutical Co., Ltd. Major Business
 Table 69. Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product and Services
 Table 70. Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 72. Jiangsu Xuantai Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
 Table 73. Chia Tai Tianqing Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
 Table 74. Chia Tai Tianqing Pharmaceutical Group Major Business
 Table 75. Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product and Services
 Table 76. Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
 Table 78. Chia Tai Tianqing Pharmaceutical Group Competitive Strengths & Weaknesses
 Table 79. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
 Table 80. Merck & Co., Inc. Major Business
 Table 81. Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product and Services
 Table 82. Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Merck & Co., Inc. Recent Developments/Updates
 Table 84. Merck & Co., Inc. Competitive Strengths & Weaknesses
 Table 85. Abbott Basic Information, Manufacturing Base and Competitors
 Table 86. Abbott Major Business
 Table 87. Abbott Sitagliptin Metformin Extended Release Tablets Product and Services
 Table 88. Abbott Sitagliptin Metformin Extended Release Tablets Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Abbott Recent Developments/Updates
 Table 90. Abbott Competitive Strengths & Weaknesses
 Table 91. Sandoz Pty Ltd Basic Information, Manufacturing Base and Competitors
 Table 92. Sandoz Pty Ltd Major Business
 Table 93. Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product and Services
 Table 94. Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Sandoz Pty Ltd Recent Developments/Updates
 Table 96. Sandoz Pty Ltd Competitive Strengths & Weaknesses
 Table 97. Global Key Players of Sitagliptin Metformin Extended Release Tablets Upstream (Raw Materials)
 Table 98. Global Sitagliptin Metformin Extended Release Tablets Typical Customers
 Table 99. Sitagliptin Metformin Extended Release Tablets Typical Distributors


List of Figures
 Figure 1. Sitagliptin Metformin Extended Release Tablets Picture
 Figure 2. World Sitagliptin Metformin Extended Release Tablets Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Sitagliptin Metformin Extended Release Tablets Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Sitagliptin Metformin Extended Release Tablets Production (2019-2030) & (K Units)
 Figure 5. World Sitagliptin Metformin Extended Release Tablets Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Sitagliptin Metformin Extended Release Tablets Production Value Market Share by Region (2019-2030)
 Figure 7. World Sitagliptin Metformin Extended Release Tablets Production Market Share by Region (2019-2030)
 Figure 8. North America Sitagliptin Metformin Extended Release Tablets Production (2019-2030) & (K Units)
 Figure 9. Europe Sitagliptin Metformin Extended Release Tablets Production (2019-2030) & (K Units)
 Figure 10. China Sitagliptin Metformin Extended Release Tablets Production (2019-2030) & (K Units)
 Figure 11. Japan Sitagliptin Metformin Extended Release Tablets Production (2019-2030) & (K Units)
 Figure 12. Sitagliptin Metformin Extended Release Tablets Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030) & (K Units)
 Figure 15. World Sitagliptin Metformin Extended Release Tablets Consumption Market Share by Region (2019-2030)
 Figure 16. United States Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030) & (K Units)
 Figure 17. China Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030) & (K Units)
 Figure 18. Europe Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030) & (K Units)
 Figure 19. Japan Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030) & (K Units)
 Figure 22. India Sitagliptin Metformin Extended Release Tablets Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Sitagliptin Metformin Extended Release Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Sitagliptin Metformin Extended Release Tablets Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Sitagliptin Metformin Extended Release Tablets Markets in 2023
 Figure 26. United States VS China: Sitagliptin Metformin Extended Release Tablets Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Sitagliptin Metformin Extended Release Tablets Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Sitagliptin Metformin Extended Release Tablets Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Market Share 2023
 Figure 30. China Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Sitagliptin Metformin Extended Release Tablets Production Market Share 2023
 Figure 32. World Sitagliptin Metformin Extended Release Tablets Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Sitagliptin Metformin Extended Release Tablets Production Value Market Share by Type in 2023
 Figure 34. Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
 Figure 35. Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
 Figure 36. World Sitagliptin Metformin Extended Release Tablets Production Market Share by Type (2019-2030)
 Figure 37. World Sitagliptin Metformin Extended Release Tablets Production Value Market Share by Type (2019-2030)
 Figure 38. World Sitagliptin Metformin Extended Release Tablets Average Price by Type (2019-2030) & (US$/Unit)
 Figure 39. World Sitagliptin Metformin Extended Release Tablets Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 40. World Sitagliptin Metformin Extended Release Tablets Production Value Market Share by Application in 2023
 Figure 41. Hospital
 Figure 42. Clinic
 Figure 43. Other
 Figure 44. World Sitagliptin Metformin Extended Release Tablets Production Market Share by Application (2019-2030)
 Figure 45. World Sitagliptin Metformin Extended Release Tablets Production Value Market Share by Application (2019-2030)
 Figure 46. World Sitagliptin Metformin Extended Release Tablets Average Price by Application (2019-2030) & (US$/Unit)
 Figure 47. Sitagliptin Metformin Extended Release Tablets Industry Chain
 Figure 48. Sitagliptin Metformin Extended Release Tablets Procurement Model
 Figure 49. Sitagliptin Metformin Extended Release Tablets Sales Model
 Figure 50. Sitagliptin Metformin Extended Release Tablets Sales Channels, Direct Sales, and Distribution
 Figure 51. Methodology
 Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Jiangsu Anbisheng Pharmaceutical Co., Ltd.
Jiangsu Xuantai Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group
Merck & Co., Inc.
Abbott
Sandoz Pty Ltd

Related Reports

Global Sitagliptin Metformin Extended Release Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Sitagliptin Metformin Extended Release Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Sep 2024

date Pharma & Healthcare

Sitagliptin Metformin Extended Release Tablets is a combination drug used to treat type 2 diabetes. Through the synergistic effect of sitagliptin and metformin, it helps patients better control blood sugar levels. This drug is suitable for patients who have poor blood sugar control through diet and exercise. It can lower blood sugar and improve insulin resistance through different mechanisms.

Product Tags

Sitagliptin Metformin Extended Release Tablets

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>